Advertisement

Topics

Vertex: A Jewel In The Biotech Space

20:05 EDT 31 Jul 2017 | Topix

After the strong Phase II data for the triple combo, I'm looking for any sustained pullback in the name to build my position. Last week Vertex reported better-than-expected Q2/2017 results , driven by a solid performance for both Orkambi and Kalydeco.

Original Article: Vertex: A Jewel In The Biotech Space

NEXT ARTICLE

More From BioPortfolio on "Vertex: A Jewel In The Biotech Space"

Quick Search
Advertisement